Marketing Plan Of Square Pharma
Executive Summary:
This is a report on a marketing plan of SQUARE Pharmaceuticals Limited, it describes how they can be marketed, and established, increased it shares value against other direct or indirect competitor. It describes the ways, strategies & tactics to make their product well accepted in the market. It discusses about their market situation, competitors position, targeted consumers, organizations objectives, this report also includes actions plans to implement to reach it is desired objectives, financial aspects & how can the organization control & evaluate all the related factors in this marketing plan.
Company Overview/Introduction:
SQUARE today symbolizes a name – a state of mind. But its journey to the growth and prosperity has been no bed of roses. From the inception in 1958, it has today burgeoned into one of the top line conglomerates in Bangladesh. Square Pharmaceuticals Ltd., the flagship company, is holding the strong leadership position in the pharmaceutical industry of Bangladesh since 1985 and is now on its way to becoming a high performance global player.
SQUARE Pharmaceuticals Limited is the largest pharmaceutical company in Bangladesh and it has been continuously in the 1st position among all national and multinational companies since 1985. It was established in 1958 and converted into a public limited company in 1991. The sales turnover of SPL was more than Taka 11.46 Billion (US$ 163.71 million) with about 16.43% market share (April 2009– March 2010) having a growth rate of about 16.72%.
.
Current Market Overview:
In Bangladesh Pharmaceutical Market, Medicine Business is one of the fastest growing portfolios. It is because of our unhealthy food habits, lifestyles, activities & overall situation says that the majority of our population suffers from Hyperacidities. That’s why this market is expanding day by day with the time passes & there are huge potential factors to introduce a new Antiulcer product in the market. And
This is a report on a marketing plan of SQUARE Pharmaceuticals Limited, it describes how they can be marketed, and established, increased it shares value against other direct or indirect competitor. It describes the ways, strategies & tactics to make their product well accepted in the market. It discusses about their market situation, competitors position, targeted consumers, organizations objectives, this report also includes actions plans to implement to reach it is desired objectives, financial aspects & how can the organization control & evaluate all the related factors in this marketing plan.
Company Overview/Introduction:
SQUARE today symbolizes a name – a state of mind. But its journey to the growth and prosperity has been no bed of roses. From the inception in 1958, it has today burgeoned into one of the top line conglomerates in Bangladesh. Square Pharmaceuticals Ltd., the flagship company, is holding the strong leadership position in the pharmaceutical industry of Bangladesh since 1985 and is now on its way to becoming a high performance global player.
SQUARE Pharmaceuticals Limited is the largest pharmaceutical company in Bangladesh and it has been continuously in the 1st position among all national and multinational companies since 1985. It was established in 1958 and converted into a public limited company in 1991. The sales turnover of SPL was more than Taka 11.46 Billion (US$ 163.71 million) with about 16.43% market share (April 2009– March 2010) having a growth rate of about 16.72%.
.
Current Market Overview:
In Bangladesh Pharmaceutical Market, Medicine Business is one of the fastest growing portfolios. It is because of our unhealthy food habits, lifestyles, activities & overall situation says that the majority of our population suffers from Hyperacidities. That’s why this market is expanding day by day with the time passes & there are huge potential factors to introduce a new Antiulcer product in the market. And